![Late Onset Pompe Disease Mimicking Rigid Spine Syndrome | Canadian Journal of Neurological Sciences | Cambridge Core Late Onset Pompe Disease Mimicking Rigid Spine Syndrome | Canadian Journal of Neurological Sciences | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0317167100016760/resource/name/firstPage-S0317167100016760a.jpg)
Late Onset Pompe Disease Mimicking Rigid Spine Syndrome | Canadian Journal of Neurological Sciences | Cambridge Core
![Function, structure and quality of striated muscles in the lower extremities in patients with late onset Pompe Disease—an MRI study [PeerJ] Function, structure and quality of striated muscles in the lower extremities in patients with late onset Pompe Disease—an MRI study [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/10928/1/fig-2-2x.jpg)
Function, structure and quality of striated muscles in the lower extremities in patients with late onset Pompe Disease—an MRI study [PeerJ]
![Muscle weakness in adults with Pompe disease. Distribution of skeletal... | Download Scientific Diagram Muscle weakness in adults with Pompe disease. Distribution of skeletal... | Download Scientific Diagram](https://www.researchgate.net/profile/Baziel-Van-Engelen/publication/233404633/figure/fig2/AS:202697836896260@1425338338821/Muscle-weakness-in-adults-with-Pompe-disease-Distribution-of-skeletal-muscle-weakness_Q320.jpg)
Muscle weakness in adults with Pompe disease. Distribution of skeletal... | Download Scientific Diagram
![Clinical features in Pompe disease. Atrophy of the quadriceps muscle... | Download Scientific Diagram Clinical features in Pompe disease. Atrophy of the quadriceps muscle... | Download Scientific Diagram](https://www.researchgate.net/publication/233404633/figure/fig1/AS:202697836896259@1425338338793/Clinical-features-in-Pompe-disease-Atrophy-of-the-quadriceps-muscle-A-scapular.png)
Clinical features in Pompe disease. Atrophy of the quadriceps muscle... | Download Scientific Diagram
![Marrow on X: "The @US_FDA Approved Nexviazyme (avalglucosidase alfa-ngpt) For Late-Onset Pompe Disease Recommended dose: 20 mg/kg for patients ≥30 kg OR 40 mg/kg for patients <30 kg | #medtwitter https://t.co/CZN4NK0X2n" / Marrow on X: "The @US_FDA Approved Nexviazyme (avalglucosidase alfa-ngpt) For Late-Onset Pompe Disease Recommended dose: 20 mg/kg for patients ≥30 kg OR 40 mg/kg for patients <30 kg | #medtwitter https://t.co/CZN4NK0X2n" /](https://pbs.twimg.com/media/E8gDnNDUcAA2py-.jpg)
Marrow on X: "The @US_FDA Approved Nexviazyme (avalglucosidase alfa-ngpt) For Late-Onset Pompe Disease Recommended dose: 20 mg/kg for patients ≥30 kg OR 40 mg/kg for patients <30 kg | #medtwitter https://t.co/CZN4NK0X2n" /
![Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study | Scientific Reports Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-29170-7/MediaObjects/41598_2018_29170_Fig1_HTML.png)
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study | Scientific Reports
![JCM | Free Full-Text | New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside JCM | Free Full-Text | New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside](https://www.mdpi.com/jcm/jcm-10-03395/article_deploy/html/images/jcm-10-03395-g001.png)
JCM | Free Full-Text | New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside
![Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder](https://www.mdpi.com/biomolecules/biomolecules-10-01339/article_deploy/html/images/biomolecules-10-01339-g001.png)